Hawk70 it’s a 10 million dollar market cap with 10 million in funding with a runway all the way to phase 2. It’s called company progression and drug development.
Secondly you’re a liar and a troll. Mesoblast had pre clinical success in 2010 and then applied for IND for phase 2. They don’t need another phase 1 and as the CEO stated in his interview they go straight to phase 2 just like MSB. Do you know what MSB market cap was on back in 2010 on pre clinical trials was over a 350 million market cap. So why was the market cap so big when apparently it was 16 mice? Your a troll
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-111
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $62.37M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 29.0¢ | $212.0K | 717.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23143 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 313746 | 2 |
View Market Depth
| Last trade - 11.49am 08/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |